Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $70.95 million. The enterprise value is $61.56 million.
| Market Cap | 70.95M |
| Enterprise Value | 61.56M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 17.18 million shares outstanding. The number of shares has increased by 117.95% in one year.
| Current Share Class | 17.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +117.95% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.92% |
| Owned by Institutions (%) | 21.93% |
| Float | 12.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.35 |
| Forward PS | 2.34 |
| PB Ratio | 16.51 |
| P/TBV Ratio | 16.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.45 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.08 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -43.98% |
| Return on Invested Capital (ROIC) | -120.04% |
| Return on Capital Employed (ROCE) | -194.72% |
| Weighted Average Cost of Capital (WACC) | 16.80% |
| Revenue Per Employee | $398,961 |
| Profits Per Employee | -$410,303 |
| Employee Count | 76 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 7.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.20% in the last 52 weeks. The beta is 1.61, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -10.20% |
| 50-Day Moving Average | 4.88 |
| 200-Day Moving Average | 5.97 |
| Relative Strength Index (RSI) | 36.78 |
| Average Volume (20 Days) | 44,807 |
Short Selling Information
The latest short interest is 202,755, so 1.18% of the outstanding shares have been sold short.
| Short Interest | 202,755 |
| Short Previous Month | 222,572 |
| Short % of Shares Out | 1.18% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 1.89 |
Income Statement
In the last 12 months, VRCA had revenue of $30.32 million and -$31.18 million in losses. Loss per share was -$1.88.
| Revenue | 30.32M |
| Gross Profit | 11.43M |
| Operating Income | -26.43M |
| Pretax Income | -31.18M |
| Net Income | -31.18M |
| EBITDA | -25.96M |
| EBIT | -26.43M |
| Loss Per Share | -$1.88 |
Balance Sheet
The company has $11.20 million in cash and $1.81 million in debt, with a net cash position of $9.39 million or $0.55 per share.
| Cash & Cash Equivalents | 11.20M |
| Total Debt | 1.81M |
| Net Cash | 9.39M |
| Net Cash Per Share | $0.55 |
| Equity (Book Value) | 4.31M |
| Book Value Per Share | 0.25 |
| Working Capital | 10.20M |
Cash Flow
| Operating Cash Flow | -13.35M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 469,000 |
| Net Borrowing | -40.23M |
| Free Cash Flow | -13.35M |
| FCF Per Share | -$0.78 |
Margins
Gross margin is 37.68%, with operating and profit margins of -87.18% and -102.84%.
| Gross Margin | 37.68% |
| Operating Margin | -87.18% |
| Pretax Margin | -102.84% |
| Profit Margin | -102.84% |
| EBITDA Margin | -85.63% |
| EBIT Margin | -87.18% |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -117.95% |
| Shareholder Yield | -117.95% |
| Earnings Yield | -43.85% |
| FCF Yield | -18.77% |
Analyst Forecast
The average price target for VRCA is $13.83, which is 234.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.83 |
| Price Target Difference | 234.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 9.92% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
VRCA has an Altman Z-Score of -13.16 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.16 |
| Piotroski F-Score | 4 |